Additionally, a lower expression of VCAM1, CCL2, and PRMT1 was observed in patients with RA-ILD+ when compared with those with IPF (p = 0.04, p = 0.05, p = 0.02, respectively, Figures 1B, D, F, Supplementary Table S1). This evidence concerns the gene CCL2 and rheumatoid arthritis.